OCREVUS (ocrelizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** OCRELIZUMAB

**Strength:** 300 mg/10mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** Genentech, Inc.

**Marketing category:** BLA (BLA761053)

**Pharmacologic class:** Antibodies, Monoclonal [CS], Antibodies, Monoclonal, Humanized [CS], CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]